Aleksey L Maslyanskiy

4PUBLICATIONS
55CO-AUTHORS
AutoimmunityDisease surveillanceImmunogenetics (incl. genetic immunology)Optical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 14, 2026
Single-cell RNA profiling suggests goflikicept-mediated immune modulation in idiopathic recurrent pericarditis.

|May 12, 2025
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA.

E L Nasonov, V I Mazurov, A M Lila

|Oct 28, 2024
[Long-term goflkicept therapy for patients with idiopathic recurrent pericarditis: results of the interim analysis of an ongoing open-label extension study].

V Y Myachikova, A L Maslyanskiy, O M Moiseeva

|Aug 04, 2021
Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study.

Evgeniy Nasonov, Saeed Fatenejad, Eugen Feist

Pageof 1

Frequent Collaborators

2 joint publications

V Y Myachikova

2 joint publications

O Moiseeva

2 joint publications

M Y Samsonov

2 joint publications

Evgeniy Nasonov